The Indian Vaccine Market: Current Market Trends and Future Prospects

NOIDA, India - Nov. 21, 2015 - PRLog -- The market for vaccines in India shows immense potential. The country has not only been self-sufficient in meeting its domestic requirements but has also emerged as a leading global exporter of vaccines across the world. The Indian vaccine industry began as a network of state owned manufacturers supplying basic childhood vaccines to the national immunization programme.  In recent decades, however, a number of privately owned firms have emerged which have completely transformed the industry landscape. Their biggest success factor is similar to the approach that has been followed by Indian generic pharmaceutical manufacturers. This model involved concerted efforts to develop vaccines for not only tropical neglected diseases, but also cheaper alternatives of vaccines that are already available in the West.

Despite its recent growth, however, the Indian vaccine industry still has a number of challenges to address. The market remains small (currently accounts for less than 2% of the global market) and underpenetrated compared to the developed countries.  The country also lags behind its global peers in terms of vaccine coverage with a significant number of lives lost due to vaccine preventable deaths. Nevertheless, despite these challenges the situation appears bright for vaccine manufacturers. The country has around 25-30 Million births each year. This coupled with the sustained growth of the Indian economy, a consequent rise in public and private healthcare expenditures and a strong growth in the market for adult vaccines is expected to propel the Indian vaccine market to grow at a CAGR of over 15% during the coming years.

IMARC’s new report entitled “Indian Vaccine Market Report and Forecast 2015-2019” provides an analytical and statistical insight into the Indian vaccine market. The study is an outcome of an intensive research on the Indian vaccine industry and draws upon a comprehensive analysis of every major vaccine in India. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian vaccine market in any form.

Key Vaccines Covered in the Report

BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, DPT, Polio, MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV

Focus of the Analysis for Each Vaccine

·         Vaccine Overview and Epidemiology

·         Historical and Current Market Trends

·         Market Breakup by Prescriber

·         Market Breakup by Public and Private Sector

·         Market Outlook

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:

Email: apac@imarcgroup.com

Phone: +91-120-415-5099

IMARC Group North America:

Email:  america@imarcgroup.com

Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:

Email:ema@imarcgroup.com

Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/indian-vaccine-market